These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26334120)

  • 1. Re: cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Klatte T
    Eur Urol; 2015 Oct; 68(4):737. PubMed ID: 26334120
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Laguna MP
    J Urol; 2015 May; 193(5):1514-5. PubMed ID: 25895755
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Heng DY; Wells JC; Rini BI; Beuselinck B; Lee JL; Knox JJ; Bjarnason GA; Pal SK; Kollmannsberger CK; Yuasa T; Srinivas S; Donskov F; Bamias A; Wood LA; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Kim JJ; Choueiri TK
    Eur Urol; 2014 Oct; 66(4):704-10. PubMed ID: 24931622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconciling the use of cytoreductive nephrectomy in the targeted therapy era.
    Culp SH
    Eur Urol; 2014 Oct; 66(4):711-2. PubMed ID: 25001889
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bilateral partial nephrectomy in a case of bilateral synchronous renal cell carcinoma].
    Takemoto J; Suzuki K; Takeuchi M
    Hinyokika Kiyo; 2003 Mar; 49(3):173-5. PubMed ID: 12728534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged response to cytoreductive surgery and sunitinib in an elderly patient with synchronous multiple metastases from renal cell carcinoma.
    Locatelli MC; Miedico A; D'Antona A; Longo G; Maggioni M; Maggioni A; Tombolini P; Tabiadon D
    Tumori; 2010; 96(3):478-82. PubMed ID: 20845812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Against: The case for cytoreductive nephrectomy for the management of metastatic renal cell carcinoma.
    Carver BS
    J Urol; 2009 Sep; 182(3):833-4. PubMed ID: 19616224
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy.
    Karam JA; Wood CG
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):753-64. PubMed ID: 21763966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC RENAL CELL CANCER].
    Nosov AK; Novik AV; Vorobiev AV; Samartseva EE; Reva SA; Baldueva IA; Lushina PA
    Vopr Onkol; 2015; 61(3):494-8. PubMed ID: 26242167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sunitinib prior to planned cytoreductive nephrectomy: is this the new litmus test for metastatic renal cell carcinoma?
    Kim SP; Thompson RH
    Eur Urol; 2011 Sep; 60(3):455-6; discussion 456-7. PubMed ID: 21680083
    [No Abstract]   [Full Text] [Related]  

  • 11. Dramatic reduction in tumor burden with neoadjuvant sunitinib prior to bilateral nephron-sparing surgery.
    Gorin MA; Ekwenna O; Soloway MS; Ciancio G
    Urology; 2012 Feb; 79(2):e11. PubMed ID: 21676439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma.
    Margulis V; Matin SF; Tannir N; Tamboli P; Swanson DA; Jonasch E; Wood CG
    J Urol; 2008 Jul; 180(1):94-8. PubMed ID: 18485389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy.
    Choueiri TK; Xie W; Kollmannsberger C; North S; Knox JJ; Lampard JG; McDermott DF; Rini BI; Heng DY
    J Urol; 2011 Jan; 185(1):60-6. PubMed ID: 21074201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we really making an advance in the treatment of metastatic renal cell carcinoma?
    Kirkali Z
    Eur Urol; 2006 Apr; 49(4):604-5. PubMed ID: 16481098
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bilateral synchronous renal cell carcinoma: report of three cases].
    Nakatsuji H; Yamashita Y; Karashima T; Hashine K; Sumiyoshi Y
    Hinyokika Kiyo; 1999 Oct; 45(10):695-8. PubMed ID: 10586361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cytoreductive nephrectomy in the era of targeted therapy for renal cell carcinoma.
    Crispen PL; Blute ML
    Curr Urol Rep; 2012 Feb; 13(1):38-46. PubMed ID: 22105577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive nephrectomy in metastatic clear-cell renal cell carcinoma: perspectives in the tyrosine kinase inhibitor era.
    Biswas S; Kelly J; Eisen T
    Oncologist; 2009 Jan; 14(1):52-9. PubMed ID: 19147692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive nephrectomy: past, present and future.
    Galazi M; Rodriguez-Vida A; Josephides E; Chau NM; Chowdhury S
    Expert Rev Anticancer Ther; 2014 Mar; 14(3):271-7. PubMed ID: 24392671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy.
    You D; Jeong IG; Ahn JH; Lee DH; Lee JL; Hong JH; Ahn H; Kim CS
    J Urol; 2011 Jan; 185(1):54-9. PubMed ID: 21074811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive nephrectomy for metastatic renal cell carcinoma.
    McKiernan J; Wood CG
    J Urol; 2013 Aug; 190(2):386-8. PubMed ID: 23702308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.